Skip to main content
Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
9.11
+0.02 (0.22%)
At close: Mar 28, 2025, 4:00 PM
9.00
-0.11 (-1.21%)
After-hours: Mar 28, 2025, 7:54 PM EDT

Gyre Therapeutics Revenue

In the year 2024, Gyre Therapeutics had annual revenue of $105.76M, down -6.78%. Gyre Therapeutics had revenue of $27.87M in the quarter ending December 31, 2024, with 2.67% growth.

Revenue (ttm)
$105.76M
Revenue Growth
-6.78%
P/S Ratio
7.33
Revenue / Employee
$182,655
Employees
579
Market Cap
852.81M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024105.76M-7.69M-6.78%
Dec 31, 2023113.45M11.16M10.91%
Dec 31, 2022102.29M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

GYRE News

More News